Saturday 17 October 2026
Export CABR’s income statement to Excel — free account
Caring Brands, Inc.
CABR Healthcare Drug Manufacturers Specialty & Generic
Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024. In the quarter to June 2026, EPS fell 102.0% and free cash flow fell 121.3%, each against the same quarter a year earlier.
1.22
0.07
−5.43%
Follow CABR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+4 more TTM periods Free account |
0.00% | 0.00% | 0.00% | (2,006.10%) | |
| (176.81%) | (539.65%) | (883.42%) | (1,033.41%) | ||
ROIC |
(67.30%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
534.78% | (292.01%) | (536.74%) | (647.02%) | |
Average Days of Receivables |
— | 0.00 | — | — | |
Free Cash Flow per Share |
(0.07) | (0.12) | (0.14) | (0.25) | |
Free Cash Flow |
(0.90) | (1.69) | (2.00) | (2.26) | |
| Other line items | |||||
Cash ROIC |
(34.55%) | (39.00%) | (6,414.42%) | 254.15% | |
Accounts Receivable Turnover |
— | 0.00 | — | — | |
Accounts Payable Turnover |
— | 0.00 | — | 0.00 | |
Inventory Turnover |
— | 0.00 | — | 0.00 | |
Average Days of Payables |
0.00 | 32,734.74 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 2,458.95 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 3,516.67% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | 0.00% | — | 0.00% | |
Interest Coverage |
— | (309.11) | (23.25) | (23.21) | |
Operating CF/Net income |
0.32 | 0.27 | 0.21 | 0.23 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.07) | (0.12) | (0.14) | (0.25) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | — | — |
Columns are period end dates